Tag: #biotech

Oramed Sells Oral-Insulin Unit to Lifeward, Takes Major Stake in Exoskeleton Maker

Oramed sells its oral drug unit to Lifeward, receiving shares, warrants, royalties and convertible notes—positioning it as a near-control shareholder.

#biotech, #medtech, #nasdaq, #exoskeleton, #convertiblenotes

Open-Source ‘DNA GPT’ Evo 2 Hits the Internet, Raising Hopes for Medicine—and New Biosecurity Questions

A new 40B-parameter genome AI, Evo 2, is released with open weights and data—boosting research while testing safeguards against biological misuse.

#ai, #genomics, #biosecurity, #openai, #biotech

After One Baby’s Custom CRISPR Rescue, a Startup Bets on Made-to-Order Gene Editing

A one-off CRISPR therapy saved a baby with a lethal mutation. Now a Doudna-backed startup and a new FDA pathway aim to scale bespoke gene medicines.

#crispr, #geneediting, #rarediseases, #fda, #biotech

Merck Acquires Modifi Biosciences in $30 Million Deal to Strengthen Oncology Portfolio

Merck acquires Modifi Biosciences to boost its cancer treatment offerings amid upcoming Keytruda patent expiration.

#merck, #acquisition, #oncology, #biotech, #cancer

Merck KGaA to Acquire SpringWorks Therapeutics for $3.9 Billion

Merck KGaA to enhance its oncology portfolio with the $3.9B acquisition of SpringWorks Therapeutics, focusing on rare tumor treatments.

#merck, #springworks, #biotech, #oncology, #acquisition